NCT02012296 2022-07-13
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
University of Chicago
Phase 1/2 Completed
Clinical Trials
3 trialsNCT02014337 2018-01-17
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Corcept Therapeutics
Phase 1 Completed
NCT00140478 2009-12-09
Mifepristone (RU-486) in Androgen Independent Prostate Cancer
Dana-Farber Cancer Institute
Phase 2 Completed